Proposed Mechanism of Action of Topically Applied Autologous Blood Clot Tissue.
| Autor: | Snyder RJ; Barry University School of Podiatric Medicine, Miami Shores, FL., Schultz G; †Institute for Wound Research, University of Florida, Gainesville, FL., Wachuku C; Barry University School of Podiatric Medicine, Miami Shores, FL., Rashid AM; Barry University School of Podiatric Medicine, Miami Shores, FL., Ead JK; ‡Westside Regional Medical Center, Plantation, FL. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of the American Podiatric Medical Association [J Am Podiatr Med Assoc] 2023 May-Jun; Vol. 113 (3). |
| DOI: | 10.7547/20-140 |
| Abstrakt: | Background: Chronic wounds, especially in patients with diabetes, often represent clinical challenges. Recently, the use of a topically applied blood clot has garnered significant interest. This stromal matrix contains viable cells that are autologous, biocompatible, biological, and consistent with a metabolically active scaffold. It has been shown to be safe, effective, and cost-efficient. However, the mechanism of action of this modality remains elusive. We sought to identify a potential mechanism of action of an autologous blood clot. Methods: Review of clinical and scientific literature hypothesizes on how autologous blood clots may stimulate healing and facilitate the movement of critical substrates while lowering bioburden and fostering angiogenesis. Results: Blood serves as a carrier for many components: red blood cells, white blood cells, platelets, proteins, clotting factors, minerals, electrolytes, and dissolved gasses. In response to tissue injury, the hemostatic mechanism uses a host of vascular and extravascular responses initiating primary, secondary, and tertiary hemostasis. The scaffold created by the autologous blood clot tissue provides a medium in which the body can transform the wound from a nonhealing chronic condition into a healing acute condition. The autologous blood clot tissue also creates a protective setting for the body to use its own mechanisms to promote wound healing in an organized manner. This transient scaffold recruits surrounding fibroblasts and promotes cell ingrowth to foster granulation tissue remodeling. Cells in this matrix sense not only soluble factors but also their physical environments. This well-orchestrated mechanism includes signals from soluble molecules, from the substrate/matrix to which the cell is adherent, from the mechanical or physical forces acting on it, and from contact with other cells. Topically applied autologous blood clot tissue can lower bacterial bioburden while stimulating angiogenesis and fostering the movement of keratinocytes and fibroblasts. Conclusions: Topically applied autologous blood clot tissue is a formidable cellular and tissue-based therapy that has been shown to be safe and effective. Although the central component of this therapy is blood, the autologous clot tissue creates a scaffold that performs as a biological delivery system that functions to control the release of growth factors and cytokines over several days. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|